ribozymes for hepatitis C(Tokyo University)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Nameribozymes for hepatitis C(Tokyo University)

Drug Alias Nameribozymes for hepatitis B(University of Connecticut)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > RibozymeSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis CHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Tokyo

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Tokyo University Of Connecticut

Active IndicationsN/A

Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A